Widespread editing of the mutated DMD gene by CRISPR–Cas9, systemically delivered via an adeno-associated virus, restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kunkel, L. M. Am. J. Hum. Genet. 76, 205–214 (2005).
Aartsma-Rus, A. et al. Hum. Mutat. 30, 293–299 (2009).
Nelson, C. E. et al. Science 351, 403–407 (2016).
Long, C. et al. Science 351, 400–403 (2016).
Tabebordbar, M. et al. Science 351, 407–411 (2016).
Amoasii, L. et al. Sci. Transl. Med. 9, eaan8081 (2017).
Bengtsson, N. E. et al. Nat. Commun. 8, 14454 (2017).
El Refaey, M. et al. Circ. Res. 121, 923–929 (2017).
McGreevy, J. W., Hakim, C. H., McIntosh, M. A. & Duan, D. Dis. Model. Mech. 8, 195–213 (2015).
Amoasii, L. et al. Science 362, 86–91 (2018).
Duan, D. Mol. Ther. 26, 2337–2356 (2018).
Mendell, J. R. et al. N. Engl. J. Med. 377, 1713–1722 (2017).
Day, M. J. J. Comp. Pathol. 137(Suppl. 1), S10–S15 (2007).
Wasala, N. B. et al. Hum. Mol. Genet. 25, 2633–2644 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D.D. is a member of the scientific advisory board for Solid Biosciences and an equity holder of Solid Biosciences. D.D.’s lab has received research support from Solid Biosciences.
Rights and permissions
About this article
Cite this article
Duan, D. CRISPR alleviates muscular dystrophy in dogs. Nat Biomed Eng 2, 795–796 (2018). https://doi.org/10.1038/s41551-018-0320-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-018-0320-0